Credit Suisse Reinstates Coverage on Teva Pharma (TEVA) at Outperform
Tweet Send to a FriendGet Alerts TEVA Hot Sheet
Price: $40.23 +0.68%
Rating Summary:
7 Buy, 16 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
7 Buy, 16 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade TEVA Now!
Credit Suisse reinstates coverage on Teva Pharma (NASDAQ: TEVA) with an Outperform (from Neutral). PT $53.00.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $41.72 yesterday, with a 52 week range of $35.00-$57.08.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $41.72 yesterday, with a 52 week range of $35.00-$57.08.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist
- Cowen Starts Triumph Group (TGI) at Neutral
- BTIG Starts Ambac Financial (AMBC) at Buy, Interesting Play with 'Optionality'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit Suisse
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
